[Close]  
Pharmaceutical market research logo; 24-years of Excellence in Market Research since 1988 roundel.


>

Point of Care Diagnostics: World Market Outlook 2012-2021

Image for Point of Care Diagnostics: World Market Outlook 2012-2021

Table of Contents

Market Study
Published: December 2011
Pages: 126
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 1699.00  Buy Now!
Research from: Visiongain
Sector: Medical Devices

How will the point of care diagnostics market perform from 2011? Our new report shows you potential sales and trends to 2021, discussing opportunities and prospects.

Discover sales for the point of care diagnostics market at segment and national/regional levels. Our report gives you business research, analysis and data.

See sales predictions and discussions for blood glucose testing, coagulation testing, cardiac marker testing and infectious diseases testing segments. Discover opportunities in these markets. Find data you need in our report.

Discover the activities and issue shaping the development of point of care diagnostics market. Through our research and analysis we aim to save you time and help in your decisions.

The market will be driven by the launch of new devices and expansion of test menus. Find R&D trends and commercial opportunities there.

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. 

Detailed analysis of the global Point of Care Diagnostics Market

Point of Care Diagnostics: World Market Outlook 2012-2021 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses, opinions from our survey and a review of companies. Discover over 90 tables and charts and a research interview (shown in the accompanying lists).

Why you should buy Point of Care Diagnostics: World Market Outlook 2012-2021

In this report, you will receive the following benefits in particular:
• You will receive our assessment of the current market for point of care diagnostic devices, with respect to the leading segments, products, companies and national markets
• You will discover sales trends for the overall point of care diagnostic devices market from 2011 to 2021 – seeing where commercial growth will occur
• You will discover sales trends for the main segments – blood glucose testing, coagulation testing, cardiac marker testing and infectious diseases testing – from 2011 to 2021, with detailed discussions of market potential
• You will receive sales forecasts for leading regional/national markets (US, Japan, Europe and Asia), with informed discussion
• You will assess leading manufacturers and products in the leading segments of the point of care diagnostics market, with information on the pipeline products
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis)  facing the point of care diagnostics market from 2011 onwards
• You will be able to investigate competition and opportunities influencing the point of care diagnostics market from 2011 onwards
• You will see what will stimulate and restrain the market from 2011
• You will discover the unmet needs in the market, driving the growth from 2011 onwards
• You will view expert opinion from our survey, including full interview transcripts.

Companies Listed

3M
A. Menarini
Abbott
Advanced Liquid Logic
AgaMatrix
AIMEDICS
Alere
Alfa Scientific Designs
American College of Cardiology (ACC)
American Heart Association (AHA)
ArKal Medical
Arkray
Bayer
BBI Healthcare
Bbraun
BD Biosciences
Becton Dickinson
Bio-AMD
BioHelix Corporation
bioLytical Laboratories
bioMerieux
Bionime
Bio-Rad Laboratories
Biorasis
Burnet Institute
Calypte Biomedical
CardioGenics
Center for Diseases Control and Prevention
Centers for Device and Radiological Health (CDRH)
Centers for Medicare & Medicaid Services (CMS)
Cepheid
Chembio Diagnostic Systems
CoaguSense
Daktari Diagnostics
DexCom
Diabetic Supply of Suncoast
Diagnostic Devices
Diagnostics for the Real World
DiME
Echo Therapeutics
Entegrion
Entra Health Systems
European Commission (EC)
European Diagnostics Manufacturers Association (EDMA)
EY Laboratories
Fifty50 Medical
Food and Drug Administration (FDA)
Fora Care
Gemeinsamer Bundesausschuss
Genesis Health Technology
Genzyme
German Federal Ministry of Health
Gluco Com
GluMetrics
GluSense
Health Protection Agency (HPA)
Helena Laboratories
Hemocellular Therapeutics
IME-DC
IND Diagnostics
Infopia
Instrumentation Laboratory
International Diabetes Federation
International Self-Monitoring Association of Oral Anticoagulated Patients (ISMAAP)
International Technidyne Corporation
IQuum
JANT Pharmacal Corporation
Johnson & Johnson
Joint United Nations Programme on HIV/AIDS (UNAIDS)
LifeScan
LifeSign
MBio Diagnostics
Medix Biochemica
MedMira
Medtronic
Meikang Biotech
Menarini
Mendor
Meridian Bioscience
Micronics
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Human Resource and Social Security (MOHRSS)
MIZUHO MEDY Company
National Health Service (NHS)
NexusDx
Nipro Diagnostics
Northwestern Global Health Foundation
Nova Biomedical
Oak Tree International Holdings
Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)
OraSure Technologies
Partec
PointCare Technologies
Princeton BioMeditech Corporation
Quidel Corporation
Randox Laboratories
Remel
Roche Diagnostics
Royal Philips Electronics
Runbio Biotech Company
SA Scientific
Savyon Diagnostics
Sekisui Medical Company
Siemens Healthcare Diagnostics
Sony Corporation
Spirit Healthcare
Systagenix Wound Management
Thermofisher
Trinity Biotech
U.S. Diagnostics
Ultradian Diagnostics
Unimed International
Universal Biosensor
University of Calgary
University of Columbia
US Department of Defense (DoD)
Walmart
Wave 80 Biosciences
Werfen Group
World Health Organization (WHO)
YD Diagnostics
Ypsomed
Zyomyx

Top of Page